Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2016 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ESTABLISHMENT LABS HLDGS INC | 19 | Q2 2024 | 6.9% |
SUMITOMO MITSUI FINL GROUP I | 18 | Q2 2024 | 17.8% |
EXAGEN INC | 18 | Q2 2024 | 1.5% |
AVADEL PHARMACEUTICALS PLC | 16 | Q4 2023 | 4.0% |
INVESCO QQQ TR | 15 | Q1 2024 | 26.4% |
APYX MEDICAL CORPORATION | 14 | Q1 2023 | 2.2% |
SPDR S&P 500 ETF TR | 14 | Q2 2024 | 0.4% |
JAWS MUSTANG ACQUISITION COR | 14 | Q2 2024 | 0.0% |
KERNEL GROUP HOLDINGS INC | 14 | Q2 2024 | 0.0% |
ROCKET PHARMACEUTICALS INC | 13 | Q2 2024 | 2.3% |
View COWEN AND COMPANY, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
OCA Acquisition Corp. | June 28, 2024 | 186,653 | 5.6% |
UroGen Pharma Ltd. | June 24, 2024 | 500,000 | 1.2% |
Slam Corp. | April 02, 2024 | 10 | 12.0% |
Fintech Ecosystem Development Corp. | March 11, 2024 | 207,806 | 5.2% |
InFinT Acquisition Corp | February 22, 2024 | 379,878 | 8.0% |
Zalatoris Acquisition Corp. | February 09, 2024 | 115,000 | 1.8% |
Andretti Acquisition Corp. | February 05, 2024 | 569,389 | 7.2% |
Churchill Capital Corp VII | February 05, 2024 | 3,630,222 | 6.3% |
Everest Consolidator Acquisition Corp | February 05, 2024 | 698,401 | 5.2% |
Power & Digital Infrastructure Acquisition II Corp. | February 05, 2024 | 715,000 | 6.7% |
View COWEN AND COMPANY, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
N-PX/A | 2024-08-30 |
N-PX | 2024-08-28 |
13F-HR | 2024-08-07 |
SC 13G | 2024-06-28 |
4 | 2024-06-24 |
SC 13G | 2024-06-24 |
3 | 2024-05-22 |
13F-HR | 2024-05-03 |
SC 13G/A | 2024-04-02 |
3 | 2024-03-15 |
View COWEN AND COMPANY, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.